Antibiotic-sparing strategies for multidrug-resistant organism (MDRO) infections

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• The increasing prevalence of multidrug-resistant organisms (MDROs), including carbapenem-resistant Enterobacteriaceae (CRE) and methicillin-resistant Staphylococcus aureus (MRSA), poses a critical threat, especially in intensive care units (ICUs).
• Overreliance on broad-spectrum antibiotics exacerbates resistance and disrupts the host microbiome, highlighting the urgent need for alternative infection control strategies.

Purpose of the Study:

• To review and synthesize current and emerging antibiotic-sparing strategies for combating MDROs.
• To explore innovations in non-antibiotic therapies, antimicrobial stewardship, and transmission prevention.

Main Methods:

• Literature review synthesizing interventions across three pillars: non-antibiotic therapies (bacteriophages, monoclonal antibodies, antimicrobial peptides), antimicrobial stewardship (diagnostics, dosing, short regimens), and transmission prevention (disinfection, hygiene, microbiota modulation).
• Analysis of key innovations such as phage-antibiotic synergy, bispecific antibody engineering, and dynamic PK/PD-TDM frameworks.

Main Results:

• Non-antibiotic therapies offer targeted pathogen lysis and biofilm disruption.
• Antimicrobial stewardship enhances precision through rapid diagnostics and optimized dosing.
• Transmission prevention strategies improve environmental hygiene and modulate host microbiota.

Conclusions:

• A combination of non-antibiotic therapies, advanced antimicrobial stewardship, and robust transmission prevention represents a paradigm shift in infection control.
• These strategies collectively reduce antibiotic dependence, slow resistance evolution, and are crucial for addressing the post-antibiotic era.
• Further research and clinical translation are needed to overcome challenges in cost-effectiveness and regulatory approval.